C54.3 Malignant neoplasm of fundus uteri

Name of the Condition

• Malignant neoplasm of fundus uteri (C54.3)
• Also known as fundal uterine cancer.

Summary

Malignant neoplasm of the fundus uteri is a type of cancer that originates in the upper, rounded portion of the uterus (the fundus). This condition is a subset of uterine cancer and may involve the endometrial lining or underlying muscular tissue. It is often associated with hormonal imbalances and may present with abnormal bleeding or other pelvic symptoms.

Causes

The exact causes are not fully understood, but hormonal factors, particularly excess estrogen without progesterone, are strongly implicated. Genetic mutations, environmental exposures, and prior medical conditions may also contribute to its development.

Risk Factors

• Advanced age, especially postmenopausal women.
• Obesity, which increases estrogen levels.
• Hormone replacement therapy (estrogen-only).
• Family history of uterine, ovarian, or colorectal cancer.
• Conditions like polycystic ovary syndrome (PCOS) or endometrial hyperplasia.
• Prior radiation therapy to the pelvic region.

Symptoms

• Abnormal vaginal bleeding (e.g., postmenopausal bleeding or heavy menstrual periods).
• Pelvic pain or pressure.
• Unusual vaginal discharge, which may be watery or blood-tinged.
• Pain during intercourse.
• Unexplained weight loss or fatigue in advanced cases.

Diagnosis

Diagnosis typically involves a combination of pelvic examination, transvaginal ultrasound to visualize uterine abnormalities, and endometrial biopsy to assess tissue samples. Hysteroscopy may be used to directly examine the uterine cavity, and imaging studies like MRI or CT scans may help evaluate the extent of the disease.

Treatment Options

Treatment depends on the stage and grade of the cancer and may include surgery (such as hysterectomy), radiation therapy, chemotherapy, or hormone therapy. The choice of treatment is tailored to the individual patient’s condition and overall health.

Prognosis and Follow-Up

Prognosis varies based on the stage at diagnosis, with earlier-stage cancers generally having better outcomes. Regular follow-up care, including pelvic exams and imaging, is important to monitor for recurrence. Long-term survival rates are generally favorable for localized disease but decrease with advanced or metastatic spread.

Complications

Complications may include metastasis to other organs, such as the lungs or bones, and treatment-related side effects like infertility, bowel or bladder dysfunction, or lymphedema. Advanced disease can also lead to severe pain or obstruction.

Lifestyle & Prevention

Maintaining a healthy weight, managing hormonal imbalances, and avoiding unopposed estrogen therapy may reduce risk. Regular screenings and prompt evaluation of abnormal bleeding are important for early detection.

When to Seek Professional Help

Seek medical attention for persistent abnormal vaginal bleeding, pelvic pain, or unusual discharge. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

When coding for malignant neoplasm of the fundus uteri (C54.3), ensure documentation specifies the anatomical location as the fundus. Verify that the diagnosis aligns with clinical findings and that any associated procedures or treatments are accurately captured. Follow coding guidelines for uterine cancers to ensure proper classification.